scPharmaceuticals Inc (SCPH)
4.28
-0.06
(-1.38%)
USD |
NASDAQ |
Oct 04, 16:00
4.27
-0.01
(-0.23%)
After-Hours: 20:00
scPharmaceuticals Shareholders Equity (Annual): 37.22M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.22M |
| December 31, 2022 | 72.43M |
| December 31, 2021 | 56.47M |
| December 31, 2020 | 82.17M |
| December 31, 2019 | 51.36M |
| Date | Value |
|---|---|
| December 31, 2018 | 78.74M |
| December 31, 2017 | 106.00M |
| December 31, 2016 | -37.07M |
| December 31, 2015 | -18.24M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
37.22M
Minimum
2023
82.17M
Maximum
2020
59.93M
Average
56.47M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Verrica Pharmaceuticals Inc | 19.76M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |